Proximal FEmur Reconstruction or Internal Fixation fOR Metastases (PERFORM) Trial
PERFORM
1 other identifier
interventional
334
4 countries
6
Brief Summary
The goal of this clinical trial is to find out if removing and replacing part of the hip bone works better than using metal hardware to stabilize the bone in patients whose cancer has spread to the hip. The main questions are:
- Be randomly assigned to one of two groups (internal fixation or resection and reconstruction).
- Have one of the two surgeries based on which group they're in.
- Go to follow-up appointments with the study doctor at 2 weeks, 6 weeks, 4 months, 6 months, 9 months, and 12 months after surgery.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Feb 2025
Longer than P75 for not_applicable
6 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 1, 2025
CompletedFirst Submitted
Initial submission to the registry
February 4, 2025
CompletedFirst Posted
Study publicly available on registry
March 7, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2029
ExpectedStudy Completion
Last participant's last visit for all outcomes
June 1, 2030
November 10, 2025
March 1, 2025
4.3 years
February 4, 2025
November 7, 2025
Conditions
Outcome Measures
Primary Outcomes (3)
Mortality at 12 months
Collected through case report forms via electronic medical records and patient/ caregiver self-reported.
From enrollment to one year follow-up post surgery.
Physical function
Patient-Reported Outcomes Measurement Information System (PROMIS®) Global Physical Function score: To what extent are you able to carry out your everyday physical activities such as walking, climbing stairs, carrying groceries, or moving a chair? Answer options include: Completely (best outcome); Mostly; Moderately; A little; Not at all (worst outcome)
From enrollment to one year follow-up post surgery.
Number of days at home
Patient self- reported via patient diary.
From enrollment to one year follow-up post surgery.
Secondary Outcomes (1)
Quality of life- PROMIS-PROPr (PROMIS-Preference) health utility score
From enrollment to one year follow-up post surgery.
Study Arms (2)
Resection and Reconstruction
EXPERIMENTALIf a participant is randomized to the Resection and Reconstruction treatment arm, a proximal femoral resection or hip arthroplasty will be carried out as per standard surgical practice. The type of endoprosthesis used for reconstruction will be at the treating surgeon's discretion. Acetabular reconstruction (if any), the surgical approach, and the intra-operative use of cement and other adjuvants for disease control will also be at the discretion of the treating surgeon.
Internal Fixation
ACTIVE COMPARATORIf the participant is randomized to the Internal Fixation treatment arm, the surgery will involve the stabilization of the remaining bone with either an intramedullary nail, plate or screw fixation. All standard surgical principles of stable internal fixation will be followed. The type of fixation, the surgical approach, and the intra-operative use of cement and other adjuvants for disease control will be at the treating surgeon's discretion.
Interventions
Eligibility Criteria
You may qualify if:
- Life expectancy of at least 6 months
- Lesions in the proximal femur (femoral neck, intertrochanteric region, subtrochanteric region, and combinations thereof)
- Low or intermediate risk for perioperative morbidity and/or mortality
- No more than 75% and no less than 25% bone loss
- Mutual (patient and physician) decision to perform surgical management of an impending or realized pathologic fracture due to MBD of the proximal has been made.
You may not qualify if:
- Lesions isolated to the femoral neck
- Lesion with any femoral head involvement
- High risk for perioperative morbidity and/or mortality
- Multidisciplinary decision that resection of the entire lesion would be indicated
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Michelle Ghert, MDlead
- Canadian Cancer Society (CCS)collaborator
Study Sites (6)
Parkview Packnett Family Cancer Institute
Fort Wayne, Indiana, 46845, United States
Good Samaritan Regional Medical Center
Corvallis, Oregon, 97330, United States
Oregon Health and Science University Hospital
Portland, Oregon, 97239, United States
Cliniques Universitaires Saint-Luc
Brussels, 1200, Belgium
Hospital de Clínicas de Porto Alegre
Porto Alegre, Rio Grande do Sul, 90450050, Brazil
AOU Città della Salute e della Scienza CTO hospital
Torino, To, 10126, Italy
Related Publications (1)
Axelrod D, Gazendam AM, Ghert M. The Surgical Management of Proximal Femoral Metastases: A Narrative Review. Curr Oncol. 2021 Sep 28;28(5):3748-3757. doi: 10.3390/curroncol28050320.
PMID: 34677238BACKGROUND
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Michelle Ghert, MD
McMaster University
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
February 4, 2025
First Posted
March 7, 2025
Study Start
February 1, 2025
Primary Completion (Estimated)
June 1, 2029
Study Completion (Estimated)
June 1, 2030
Last Updated
November 10, 2025
Record last verified: 2025-03
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL
- Time Frame
- Throughout study period.
- Access Criteria
- Publicly available.
Protocol will be shared with other researchers via the study website.